RT Journal Article
SR Electronic
T1 Predicting 30-Day All-Cause Readmission Risk for Subjects Admitted With Pneumonia at the Point of Care
JF Respiratory Care
FD American Association for Respiratory Care
SP 43
OP 49
DO 10.4187/respcare.05719
VO 63
IS 1
A1 Umur Hatipoğlu
A1 Brian J Wells
A1 Kevin Chagin
A1 Dhruv Joshi
A1 Alex Milinovich
A1 Michael B Rothberg
YR 2018
UL http://rc.rcjournal.com/content/63/1/43.abstract
AB BACKGROUND: The pneumonia 30-d readmission rate has been endorsed by the National Quality Forum as a quality metric. Hospital readmissions can potentially be lowered by improving in-hospital care, transitions of care, and post-discharge disease management programs. The purpose of this study was to create an accurate prediction model for determining the risk of 30-d readmission at the point of discharge.METHODS: The model was created using a data set of 1,295 hospitalizations at the Cleveland Clinic Main Campus with pneumonia over 3 y. Candidate variables were limited to structured variables available in the electronic health record. The final model was compared with the Centers for Medicare and Medicaid Services (CMS) model among subjects 65 y of age and older (n = 628) and was externally validated.RESULTS: Three hundred thirty subjects (25%) were readmitted within 30 d. The final model contained 13 variables and had a bias-corrected C statistic of 0.74 (95% CI 0.71–0.77). Number of admissions in the prior 6 months, opioid prescription, serum albumin during the first 24 h, international normalized ratio and blood urea nitrogen during the last 24 h were the predictor variables with the greatest weight in the model. In terms of discriminative performance, the Cleveland Clinic model outperformed the CMS model on the validation cohort (C statistic 0.69 vs 0.60, P = .042).CONCLUSIONS: The proposed risk prediction model performed better than the CMS model. Accurate readmission risk prediction at the point of discharge is feasible and can potentially be used to focus post-acute care interventions in a high-risk group of patients.